3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase 2/3
1
Status
Unknown
1
Not yet recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
2
Conditions
Prostatic Neoplasms
51
Oligometastatic Prostate Cancer
2
Neoplasm Metastasis
2
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
2
Metastatic Castration-resistant Prostate Cancer
2
Triple Negative Breast Neoplasms
1
Stage IV Prostate Adenocarcinoma AJCC v7
1
Prostate CA
1
Prostate Adenocarcinoma
1
PSA Level Greater Than 0.03
1
Non-metastatic, Hormone naïve Prostate Cancer
1
Lymphatic Metastasis
1
Hormone Sensitive Prostate Cancer
1
Breast Neoplasms
1
Adenocarcinoma
1
Interventions
Androgen Antagonists
2
zimberelimab
1
quemliclustat
1
Radiosurgery
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
Oligometastatic Prostate Cancer
×
Androgen Antagonists
×
Clear all
NCT07490210
2026-03-24
OMPC-RPM
Fudan University
Phase 2
Not yet recruiting
300 enrolled
NCT03940235
2023-06-28
RADIOSA
European Institute of Oncology
Phase 2
Unknown
150 enrolled